Royalty Pharma Makes Sweetened $8B Bid For Elan
Royalty Pharma Inc. on Friday upped its offer for Elan Corp. PLC to a possible $8 billion, its latest in a string of hostile bids aimed at countering the company's pursuit...To view the full article, register now.
Already a subscriber? Click here to view full article